Page last updated: 2024-10-24

peptidyl-lysine oxidation

Definition

Target type: biologicalprocess

The oxidation of the terminal amino-methylene groups of peptidyl-L-lysine or peptidyl-5-hydroxy-L-lysine to aldehyde groups to form allysine or hydroxyallysine residues, respectively; these are intermediates in the formation of covalent cross-links between adjacent polypeptide chains in proteins such as collagens. [ISBN:0198547684, RESID:AA0121]

Peptidyl-lysine oxidation is a post-translational modification (PTM) that involves the addition of an oxygen atom to the side chain of lysine residues in proteins. This process can occur on both free lysine residues and those within specific protein motifs. The oxidation of lysine residues can lead to a variety of functional changes in proteins, including changes in their structure, stability, and activity.

One of the most common forms of peptidyl-lysine oxidation is the formation of hydroxylysine. This modification is catalyzed by lysyl hydroxylases, a family of enzymes that utilize molecular oxygen and α-ketoglutarate as cofactors. Hydroxylysine residues are commonly found in collagen, where they play a role in the formation of strong intermolecular cross-links.

Another important form of peptidyl-lysine oxidation is the formation of Nε-(carboxymethyl)lysine (CML). This modification is formed through the reaction of lysine residues with glyoxal, a reactive dicarbonyl species. Glyoxal is a byproduct of glucose metabolism and can accumulate in tissues under conditions of oxidative stress. CML has been implicated in a variety of age-related diseases, including diabetes and Alzheimer's disease.

Peptidyl-lysine oxidation can also occur through the formation of advanced glycation end products (AGEs). AGEs are complex heterogeneous structures formed through the non-enzymatic glycation of proteins by sugars. The reaction of lysine residues with sugars can lead to the formation of a variety of AGE structures, including Nε-carboxymethyllysine (CML), Nε-(carboxyethyl)lysine (CEL), and pyrraline.

Peptidyl-lysine oxidation has been implicated in a wide range of biological processes, including:

* **Protein folding and stability:** Oxidation of lysine residues can alter the conformation of proteins, leading to changes in their stability and activity.
* **Protein-protein interactions:** Oxidation of lysine residues can affect the ability of proteins to interact with other proteins.
* **Cellular signaling:** Oxidation of lysine residues can alter the activity of signaling proteins.
* **Cellular stress response:** Peptidyl-lysine oxidation can be a marker of cellular stress and can trigger the activation of stress response pathways.

The biological significance of peptidyl-lysine oxidation depends on the specific lysine residue that is modified, the type of modification, and the cellular context. Understanding the role of peptidyl-lysine oxidation in different biological processes is essential for developing novel therapies for a variety of diseases.'
"

Proteins (5)

ProteinDefinitionTaxonomy
Protein-lysine 6-oxidase[no definition available]Bos taurus (cattle)
Lysyl oxidase homolog 4A lysyl oxidase homolog 4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96JB6]Homo sapiens (human)
Lysyl oxidase homolog 2A lysyl oxidase homolog 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y4K0]Homo sapiens (human)
Lysyl oxidase homolog 3A lysyl oxidase homolog 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P58215]Homo sapiens (human)
Protein-lysine 6-oxidaseA protein-lysine 6-oxidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P28300]Homo sapiens (human)

Compounds (15)

CompoundDefinitionClassesRoles
phenethylamine2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.

phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
alkaloid;
aralkylamine;
phenylethylamine
Escherichia coli metabolite;
human metabolite;
mouse metabolite
pyrithionepyrithione : A pyridinethione that is pyridine-2(1H)-thione in which the hydrogen attached to the nitrogen is replaced by a hydroxy group. It is a Zn(2+) ionophore; the zinc salt is used as an antifungal and antibacterial agent.

pyrithione: split from cephalosporin molecule; some metal complexes of this have fumarate reductase inhibitory activity and may be useful against trypanosomes; RN given refers to parent cpd; structure
monohydroxypyridine;
pyridinethione
ionophore
aminopropionitrileAminopropionitrile: Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid.aminopropionitrileantineoplastic agent;
antirheumatic drug;
collagen cross-linking inhibitor;
plant metabolite
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
thiramthiram : An organic disulfide that results from the formal oxidative dimerisation of N,N-dimethyldithiocarbamic acid. It is widely used as a fungicidal seed treatment.

Thiram: A dithiocarbamate chemical, used commercially in the rubber processing industry and as a fungicide. In vivo studies indicate that it inactivates the enzyme GLUTATHIONE REDUCTASE. It has mutagenic activity and may induce chromosomal aberrations.
organic disulfideantibacterial drug;
antifungal agrochemical;
antiseptic drug
benzylamineaminotoluene : Any member of the class of toluenes carrying one or more amino groups.aralkylamine;
primary amine
allergen;
EC 3.5.5.1 (nitrilase) inhibitor;
plant metabolite
4-nitrobenzylamine4-nitrobenzylamine: RN given refers to parent cpd
1-deoxynojirimycin1-deoxy-nojirimycin: structure in first source

duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration.
2-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid
anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
miglustatmiglustat : A hydroxypiperidine that is deoxynojirimycin in which the amino hydrogen is replaced by a butyl group.

miglustat: a glucosylceramide synthase inhibitor
piperidines;
tertiary amino compound
anti-HIV agent;
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
4-fluorobenzylamine
4-pyridylmethylamine4-pyridylmethylamine: structure given in first source
mor-14N-methyldeoxynojirimycin: glucosidase inhibitorhydroxypiperidine;
piperidine alkaloid;
tertiary amino compound
anti-HIV agent;
cardioprotective agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
plant metabolite
homonojirimycinhomonojirimycin: inhibits alpha-glucosidase; RN given for (2R-(2alpha,3alpha,4beta,5alpha,6beta))-isomer; structure in first source
n-nonyl-1-deoxynojirimycinN-nonyldeoxynojirimycin : A hydroxypiperidine that is deoxynojirimycin (duvoglustat) in which the amino hydrogen is replaced by a nonyl group.hydroxypiperidine;
tertiary amino compound
antiviral agent;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
EC 3.2.1.45 (glucosylceramidase) inhibitor
somatostatinheterodetic cyclic peptide;
peptide hormone